Welcome to TypeOneNation 2014. The Plan for a World without T1D Presented by: Carol Oxenreiter Saturday, May 31, 2014.

Slides:

Advertisements

Similar presentations

Diabetes and Heart Disease

Advertisements

 Objectives ◦ Show video explaining fixed carb ratio insulin therapy. ◦ Show video explaining intensive insulin therapy. ◦ Show video explaining pump.

Past, Present and the Future Rabin Mohanty Consultant Paediatrician Blackpool.

JDRF Advocacy: Advancing Life- Changing Therapies

Continuous Glucose Monitoring

Stem Cells and Diabetes The Present. Background Diabetes affects more people and causes more deaths each year than breast cancer and AIDS combined. The.

The Great Diabetes Epidemic: A Manifesto for Action.

An example of a critical system

CURING T1D IS A GLOBAL, COORDINATED EFFORT 555 ACTIVE RESEARCH PROJECTS Note: JDRF research portfolio review September 2014.

Turning TypeOne to The Plan for a World without T1D.

Reverse Vaccine in Type 1 DM

1 Presentation to NIH Scientific Management Review Board October 24, 2013 Concepcion R. Nierras, Ph.D. Assistant Vice President, International Partnerships,

 Type one diabetes is a disease that takes place within your body and what it means is your body does not produce insulin. This is a problem because.

By: Alicia Myall.  Also known as “insulin dependant diabetes” or “juvenile onset diabetes”  Life long illness  Most likely to be diagnosed in children,

Daniel Burukhin, Kyle Yoshihara, Jack Curtis, Graham Wrightson, Jacob Jorgensen.

Source: Site Name and Year IHS Diabetes Audit Diabetes Health Status Report ______Site Name_________ Health Outcomes and Care Given to Patients with Diabetes.

Control of Energy The Original Biofuels. Importance of Glucose Regulation Too little – Brain problems Too much –Osmotic water loss (cellular and systemic)

DO NOW. The immune systems help to protect against pathogens. If the immune system recognizes an antigen, it will launch an attack.

The Endocrine system Glands and hormones.

GENE THERAPY FOR DIABETES Lindsey Rowbotham Period 7.

Conference on Diabetes Types of diabetes mellitus type 1 -- insulin dependent type 2 – insulin independent Experiment with type 1 genetic or environmental.

Future Pharmaceutical Sciences and Recent Advancement of Medical Sciences Kunio KAWAMURA, Ph.D. Otsuka Pharmaceutical Co. Ltd.

Diabetes Mellitus For high school and college students By Emily Freedman A disease that disrupts normal metabolism, interfering with cells’ ability to.

Turning TypeOne to The Plan for a World without T1D JDRF Translational Development: Partnering for Success.

Douglas Todey. Functions The system is made up of glands that produce and secrete hormones to regulate the activity of cells and organs The hormones regulate.

Regulation of insulin levels Starter: what do each of the following cells produce and are they part of the endocrine or exocrine system; –α cells –β cells.

1 Transforming JDRF Research. Impacting Lives. Julia L. Greenstein, PhD AVP Cure Therapies April 10, 2012.

Pediatric Endocrinology Use of Biologic and Chemotherapeutic Agents Pediatric Endocrinology Use of Biologic and Chemotherapeutic Agents.

The genetic bases BY Casey Jaroche

Endocrine System – Clinical Application 1.HGH, Steroids, EPO (Erythroprotein) “Blood doping” 2.HGH – Enlarges muscles, may cause cancer and lead to carpal.

Diabetes Mellitus Type 1 By: Jennifer Marks. What is it… Also known as juvenile diabetes, or juvenile- onset diabetes It’s an autoimmune disease that.

Diabetes: What’s New? What’s Next? Robert P. Hoffman, M.D. Grand Rounds June 1, 2007.

Nursing Management: Diabetes Mellitus

Diabetes By Dylan, Amber, Catherine. Types of diabetes There are three main types of diabetes There are three main types of diabetes Type 1 diabetes is.

Gene therapy for cystic fibrosis. 1.The possibility of replacing a defective gene with a ‘good’ copy of the gene to overcome the problems caused by the.

Diabetes. PANCREAS Regulates blood sugar levels and glucose metabolism Secretes 2 hormones Insulin-allows blood sugar (glucose) to be taken out of the.

Less Until None: A Plan for a World without T1D. 2 LESSUNTILNONE 2 JDRF’s Vision for the Future.

Type 1 diabetes is an auto-immune disease in which the body's immune system destroys the insulin-producing beta cells in the pancreas. It is triggered.

Diabetes. The Food You Eat is Broken Down Into Glucose to Supply Energy to Your Cells.

Aim How does diabetes lead to a failure of homeostasis?

Maintaining Blood Glucose Levels ag ag.

“Diabetes” When blood sugar is out of control. What happens if the body can’t handle carbs normally? One result is diabetes. This can be detected by a.

DHANANG SURYA PRAYOGA CHRISTIAN DENNIS DIABETES MELLITUS.

Diabetes and Stem Cells. Diabetes Year 2000 – Estimated 171 million people Year 2013 – Estimated 343 million people Class as an epidemic.

Type I Diabetes Juvenile diabetes – develops early in life Beta cells in pancreas do not produce insulin Genetic predisposition – virus may trigger an.

高分子生物材料人工器官张国庆

Diabetes. Warm Up Questions How many people do you know have diabetes? What is diabetes? Diabetes can be dangerous if it’s not treated. What happens if.

Diabetes Pancreas Runs on Batteries. Diabetes is the common health issue in the present days. Diabetes is a condition in which blood glucose levels are.

Hormonal coordination

NOT A NEW CONCEPT: Really ‘Back to the Future’

Mean rates of insulin and glucagon delivery from an artificial pancreas at various blood glucose levels. The device was programmed to establish and maintain.

Research in T1D Cumming School of Medicine Department of Paediatrics

Diabetes Health Status Report

Type 1 diabetes and stem cells

New Patient-Friendly Options for Managing Insulin Dosing

A review of the new Eversense CGM System

How it works and why it’s important!

Volume 22, Issue 6, Pages (June 2018)

Panelists. One Size May Not Fit All: A New Aspirin Option for the High-Risk Patient.

Simplifying Insulin Delivery for Better Patient Outcomes in T2D

Diabetes and Cardiovascular Disease Risk: The Hard Truth

Diabetes and Cardiovascular Disease Risk: The Hard Truth

Aim: 3rd Quarter Cumulative Review

Statins, Obesity, and Hyperlipidemia

Jennifer McVean, MD September 23, 2010

Hormones that Affect Blood Sugar

Effect of metformin on glycemic control, insulin secretion, and insulin sensitivity in T2D. Effect of metformin on glycemic control, insulin secretion,

Zn2+ and NAD(P)H content in Mafa∆panc and Mafa∆panc;Mafb+/− β-cells.

Presentation transcript:

Welcome to TypeOneNation 2014

The Plan for a World without T1D Presented by: Carol Oxenreiter Saturday, May 31, 2014

JDRF’s Vision for the Future 3 FOR A WRLD WITHOUT TYPE 1 DIABETES

4 LESS UNTIL NONE

5 LESS UNTIL NONE LESS LESS UNTIL NONE Burden Invasive Complexity Danger

6 Delivery of Continuous Therapeutic Improvements Side-Effects Complications Patient Burden Glycemic Control Safety Normal Physiology Restored TherapiesCure Easier, Safer, Less Worry, Better Life

The Plan: Work the Pipeline 7 DELIVERY TO PATIENTS

8

Artificial Pancreas A series of systems that will automate insulin dosing and additional hormone delivery

Artificial Pancreas A series of systems that will automate insulin dosing and additional hormone delivery Smart Insulin Single dose of insulin that delivers insulin only where and when needed

Artificial Pancreas Single dose of insulin that delivers insulin only where and when needed Smart Insulin Encapsulation Implantable, beta cell replacement therapies restoring insulin independence without the need for intensive immune suppression

Artificial Pancreas Smart Insulin Encapsulation Encapsulation Implantable, beta cell replacement therapies restoring insulin independence without the need for intensive immune suppression Prevention Slow or stop the progression of T1D before insulin dependence and ultimately eliminate the possibility of ever developing T1D

Artificial Pancreas Smart Insulin Encapsulation Prevention Prevention Slow or stop the progression of T1D before insulin dependence and ultimately eliminate the possibility of ever developing T1D Restoration Beta cell growth protected from immune attack restoring insulin independence without immune suppression

Artificial Pancreas Smart Insulin Encapsulation RestorationPrevention Restoration Beta cell growth protected from immune attack restoring insulin independence without immune suppression

Artificial Pancreas Smart Insulin Encapsulation RestorationPrevention

Continuous Therapeutic Improvements NEAR TERM Complications Diabetic Eye Disease Predictive Diagnostics Artificial Pancreas Low Glucose Suspend Treat-to-Range MID TERM Encapsulation Treat-to-Target Multihormone Encapsulation Implantable Islets Smart Insulin Control Prevention Secondary Prevention LONG TERM Prevention Primary: Vaccine Complications Comprehensive Prevention Therapy Restoration New Beta Cell Growth Protected from Immune Attack

DELIVERY TO PATIENTS

Capabilities Across All Stages of the Pipeline DELIVERY TO PATIENTS $500 Million Research Portfolio Broad and Diverse Portfolio Artificial PancreasRestorationSmart InsulinEncapsulationPrevention

DELIVERY TO PATIENTS Capabilities Across All Stages of the Pipeline Research and Development Expertise

DELIVERY TO PATIENTS Capabilities Across All Stages of the Pipeline Volunteer Engagement

Capabilities Across All Stages of the Pipeline International Reach DELIVERY TO PATIENTS

Capabilities Across All Stages of the Pipeline Partnership DELIVERY TO PATIENTS

Your Support Capabilities Plan Vision

24